LOS ANGELES, March 7, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, has announced a class action lawsuit against Intellia Therapeutics, Inc. (“Intellia” or “the Company”) NTLA for alleged violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5 as set by the U.S. Securities and Exchange Commission.

The lawsuit primarily affects investors who purchased the Company’s securities during the class period of July 30, 2024 to January 8, 2025, inclusive. Those affected are encouraged to reach out to the firm before the deadline of April 14, 2025.

If you’ve suffered financial losses as a shareholder, click here to participate in the class action.

For further inquiries, please contact Brian Schall at the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335 for a free consultation regarding your rights. You can also reach the firm via their website at www.schallfirm.com, or by email at bschall@schallfirm.com.

It is important to note that the class has not yet been certified. Until certification, investors are not officially represented by an attorney. Failure to act may result in remaining an absent class member.

The Complaint indicates that Intellia made several false and misleading statements regarding the development and marketing of NTLA-3001. The Company created a misleading narrative about its capability to advance the drug, suggesting it had the necessary resources and timelines to ensure a successful launch. However, the Complaint asserts that the delivery methods were expensive and inefficient, leading to an inability to provide timely doses. Consequently, these public statements were deemed false and materially misleading, resulting in investor damages upon the revelation of the truth about Intellia’s situation.

Join the case and take the opportunity to recover your losses.

The Schall Law Firm is known for representing countless investors globally and is experienced in handling securities class action lawsuits and shareholder rights litigation.

This announcement may be categorized as Attorney Advertising in certain jurisdictions as dictated by the relevant laws and ethical rules.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

View original content to download multimedia: here.

SOURCE: The Schall Law Firm